MIT Center for Biomedical Innovation

Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.
MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.
Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.

CBI provides integrated solutions to global health

CBI Activities

Collaboration

MIT CBI is home to the Biomanufacturing Consortium (BioMAN), and the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB). These pre-competitive programs provide a safe haven where industry, academia, and government collaboratively address challenges in manufacturing, delivery, and access to biologics through focused events and projects that address key challenges in biomanufacturing.

See our Collaboration

Education

MIT CBI has developed a number of biomanufacturing-related educational offerings including a residential MIT course, an on-line course on the principles of manufacturing protein and antibody drugs, and a short course on vaccine manufacturing offered jointly with University College London. We have developed a blended learning course for the training of cell therapy manufacturing personnel which will combine online learning with hands-on training.

See our Education

Research

MIT CBI research projects focus on biomanufacturing process innovation for production of biologic medicines including monoclonal antibodies, vaccines, viral vectors, and cell therapies. Our main research areas include process analytical technologies, biomanufacturing data analytics, advanced process modeling and control, and continuous manufacturing.

See our Research

Upcoming Events

Jun

03

2025 Vaccines Bioprocess Development & Commercialization Workshop

From June 3, 2025 to June 5, 2025

100 Main St, Building E62-250, Cambridge, MA, 100 Main St, Building E62-250, Cambridge, MA 02139

Sep

10

2025 BioMAN Workshop

From September 10, 2025 to September 11, 2025

Samberg Conference Center, 50 Memorial Drive, Cambridge MA

View All Events

Latest News & Research

ONLINE COURSE ABOUT CELL THERAPIES ENROLLING NOW!

This nine-week self-paced course launches March 9th, 2022. Learn more and enroll HERE!
Biomanufacturing@MIT-CBI Research Published in ‘Biomaterials’.

Biomanufacturing@MIT-CBI researchers provide an in-depth analysis of bioprocess technologies needed for cell-based meat production and challenges in reaching commercial scale.…
The world needs more vaccines faster. A tiny tube could make all the difference.

Professor Richard Braatz was interviewed for an article in National Geographic about efforts to develop a continuous manufacturing processes…

View All News

Our Team

CBI’s core strength is in our team’s cross-cutting experience and expertise in medicine, biology, chemistry, biomanufacturing, academic & clinical research, economics, engineering, data analytics, regulatory science and public policy.

Meet the Team

Our Members

Our members and collaborators are leading stakeholders across the global healthcare value chain, from R&D and manufacturing to delivery and reimbursement.